99% Savings - Buy Just @1 Rs X
Vomilast is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Vomilast safe for pregnant women?
Pregnant women can take Vomilast without worrying about any side effects.
Is the use of Vomilast safe during breastfeeding?
Vomilast does not show any harmful effects in lactating women.
What is the effect of Vomilast on the Kidneys?
Vomilast does not damage the kidneys.
What is the effect of Vomilast on the Liver?
Vomilast does not damage the liver.
What is the effect of Vomilast on the Heart?
Using Vomilast does not have any harmful effects on the heart.
Vomilast should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Vomilast unless your doctor advises you to do so -
Is this Vomilast habit forming or addictive?
Vomilast is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Vomilast since it will not make you feel sleepy.
Is it safe?
Yes, but consume Vomilast only on doctor's advice.
Is it able to treat mental disorders?
Vomilast is unable to treat or cure mental disorders.
Interaction between Food and Vomilast
Taking Vomilast with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Vomilast
Information about the interaction of Vomilast and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 469
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclegis (doxylamine succinate and pyridoxine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611